IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
- PMID: 32194572
- PMCID: PMC7066259
- DOI: 10.3389/fimmu.2020.00388
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Abstract
The importance of the kynurenine pathway in normal immune system function has led to an appreciation of its possible contribution to autoimmune disorders such as rheumatoid arthritis. Indoleamine-2,3-dioxygenase (IDO) activity exerts a protective function, limiting the severity of experimental arthritis, whereas deletion or inhibition exacerbates the symptoms. Other chronic disorder with an inflammatory component, such as atherosclerosis, are also suppressed by IDO activity. It is suggested that this overall anti-inflammatory activity is mediated by a change in the relative production or activity of Th17 and regulatory T cell populations. Kynurenines may play an anti-inflammatory role also in CNS disorders such as Huntington's disease, Alzheimer's disease and multiple sclerosis, in which signs of inflammation and neurodegeneration are involved. The possibility is discussed that in Huntington's disease kynurenines interact with other anti-inflammatory molecules such as Human Lymphocyte Antigen-G which may be relevant in other disorders. Kynurenine involvement may account for the protection afforded to animals with cerebral malaria and trypanosomiasis when they are treated with an inhibitor of kynurenine-3-monoxygenase (KMO). There is some evidence that changes in IL-10 may contribute to this protection and the relationship between kynurenines and IL-10 in arthritis and other inflammatory conditions should be explored. In addition, metabolites of kynurenine downstream of KMO, such as anthranilic acid and 3-hydroxy-anthranilic acid can influence inflammation, and the ratio of these compounds is a valuable biomarker of inflammatory status although the underlying molecular mechanisms of the changes require clarification. Hence it is essential that more effort be expended to identify their sites of action as potential targets for drug development. Finally, we discuss increasing awareness of the epigenetic regulation of IDO, for example by DNA methylation, a phenomenon which may explain differences between individuals in their susceptibility to arthritis and other inflammatory disorders.
Keywords: 3-hydroxyanthranilic acid; Huntington's disease; T-cells; arthritis; kynurenine; lymphocyte antigens.
Copyright © 2020 Huang, Ogbechi, Clanchy, Williams and Stone.
Figures
Similar articles
-
IDO activation, inflammation and musculoskeletal disease.Exp Gerontol. 2020 Mar;131:110820. doi: 10.1016/j.exger.2019.110820. Epub 2019 Dec 26. Exp Gerontol. 2020. PMID: 31884118 Review.
-
Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.Cardiovasc Res. 2015 May 1;106(2):295-302. doi: 10.1093/cvr/cvv100. Epub 2015 Mar 5. Cardiovasc Res. 2015. PMID: 25750192
-
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:304-13. doi: 10.1016/j.pnpbp.2013.08.008. Epub 2013 Oct 31. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24184687 Review.
-
Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.Int Immunopharmacol. 2019 Aug;73:527-538. doi: 10.1016/j.intimp.2019.05.039. Epub 2019 Jun 5. Int Immunopharmacol. 2019. PMID: 31176083
-
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.Transplantation. 2007 Jul 15;84(1 Suppl):S17-20. doi: 10.1097/01.tp.0000269199.16209.22. Transplantation. 2007. PMID: 17632406
Cited by
-
Gut Microbiota Mediates Neuroinflammation in Alzheimer's Disease: Unraveling Key Factors and Mechanistic Insights.Mol Neurobiol. 2024 Sep 25. doi: 10.1007/s12035-024-04513-w. Online ahead of print. Mol Neurobiol. 2024. PMID: 39317889 Review.
-
The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy.Int J Mol Sci. 2024 Aug 20;25(16):9040. doi: 10.3390/ijms25169040. Int J Mol Sci. 2024. PMID: 39201726 Free PMC article. Review.
-
Systematic Insights into the Relationship between the Microbiota-Gut-Brain Axis and Stroke with the Focus on Tryptophan Metabolism.Metabolites. 2024 Jul 24;14(8):399. doi: 10.3390/metabo14080399. Metabolites. 2024. PMID: 39195495 Free PMC article. Review.
-
Bibliometric analysis of research on digestive system tumors and depression.Front Psychol. 2024 Aug 2;15:1414528. doi: 10.3389/fpsyg.2024.1414528. eCollection 2024. Front Psychol. 2024. PMID: 39156806 Free PMC article.
-
The improvement effect of exercise on rats with chronic stress-induced depression-like behavior: a discussion based on the kynurenine pathway.J Int Med Res. 2024 Jul;52(7):3000605241261986. doi: 10.1177/03000605241261986. J Int Med Res. 2024. PMID: 39068530 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials